Securities Snapshot

In This Issue: Jury Returns Complete Defense Verdict for Exxon and Its Officers in Securities Fraud Case; Class Certification Denied in Securities Fraud Action Against Battery Technology Company, Finding “Mismatch” Between Alleged Misstatement and Corrective Disclosures; Northern District of California Denies Motion to Dismiss Securities Fraud Claims Against Electric Vehicle Charging Company; Eastern District of Wisconsin Partially Grants Motion for Attorneys’ Fees Against the Rosen Law Firm Following Groundless Securities Fraud Complaint; Northern District of California Dismisses Claims Against Debit and Credit Card Transaction Processor Based on Underlying Antitrust Claims; Second Circuit Affirms Dismissal of Securities Claims Against Clothing Manufacturer and Retailer Based on Allegedly Misleading Risk Disclosures; District of New Jersey Dismisses With Prejudice Securities Fraud Claims Against a Telecommunications Company Arising From Environmental Issues; Central District of California Dismisses Securities Act Claim Against Caitlyn Jenner Arising From $JENNER Memecoin

Read more about these decisions and others in this month’s edition of Securities Snapshot.

In This Issue: Southern District of New York Dismisses Fraud Claims Against Auditor Related to de-SPAC Transaction; Southern District of New York Dismisses ‘Channel Stuffing’ Securities Fraud Claims Against Auto Manufacturer; District of Connecticut Largely Denies Motion to Dismiss Securities Fraud Claims Against Digital Currency Group Arising from Cryptocurrency Lending Program; Northern District of California Jury Finds Elon Musk Liable for Securities Fraud in Connection with Twitter Acquisition; Northern District of California Allows Channel-Stuffing and Backlog Fraud Claims to Proceed Against Computer Network Hardware Manufacturer; Massachusetts District Court Grants Dismissal of Securities Fraud Claims Against Biotech Company; Second Circuit Affirms Dismissal of Securities Act Claims Arising From Reverse Securities Split, Holding That Reverse Split Was Not A ‘Sale’ And That Post-Split Securities Were Not Traceable To Allegedly Misleading Registration Statement; District of Massachusetts Denies Motions to Dismiss SEC’s Securities Fraud Claims Against Pharmaceutical Executives Who Allegedly Hid Negative FDA Feedback

Read more about these decisions and others in this month’s edition of Securities Snapshot.